Wednesday, May 31, 2017

Monument to peer review unveiled in Moscow : Nature News & Comment

A 1.5-tonne stone tribute to peer review is the latest addition to Moscow’s rich cultural heritage.

On 26 May, a good-humoured crowd of more than 100 people — including students, researchers and Russia’s deputy minister of education and science — gathered outside Moscow’s Higher School of Economics (HSE) to witness the unveiling of what is probably the world's first monument to peer review.



Grant application rejected over choice of font : Nature News & Comment

Grant application rejected over choice of font : Nature News & Comment: "e of equivalent size to Arial 11”. The guidelines add: “Arial narrow and Calibri are not allowable font types and any proposal which has used either of these font types within their submission will be rejected”."



'via Blog this'

The best-kept secrets to winning grants : Nature News & Comment

The best-kept secrets to winning grants : Nature News & Comment:



'via Blog this'

Tuesday, May 30, 2017

Sharing Clinical and Genomic Data on Cancer — The Need for Global Solutions — NEJM

Sharing Clinical and Genomic Data on Cancer — The Need for Global Solutions — NEJM: "
The Cancer Moonshot has captured the imagination of researchers, patients, and the public. Putting its ideas into practice will be possible only through the use of an interoperable, scalable data framework in which the quality of data is maintained. Despite the efforts outlined above, this work is still in the early stages. Even with substantial enthusiasm for data sharing and an ever-expanding volume of genomic data sets, the inability to routinely correlate longitudinal clinical information with precise genomic data within a secure and acceptable framework continues to hamper the development of innovative data-driven care pathways for patients with cancer — as does uncertainty regarding the financial sustainability of international data sharing. We believe creating a global informatics ecosystem in which precision oncology seamlessly transitions from cancer diagnosis to molecular discovery to patient recovery must be our common goal.
"



'via Blog this'